Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Rome, Roma 168

0 studies enrolling now · 2 studies all time

What they study most

Chemotherapeutic Toxicity, Colorectal Cancer Metastatic, Endometriosis, Myelosuppression-Adult

Studies at this site

• A Study to Investigate Efficacy and Safety of OG-6219 BID in 3 Dose Levels Compared With Placebo in Participants Aged 18 to 49 With Moderate to Severe Endometriosis-related Pain — Completed
• Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving FOLFOXIRI/Bevacizumab for Metastatic Colorectal Cancer (mCRC): — Stopped early